March, 13 2025 Thursday 13:36 Hrs
  • SENSEX :   74,009.47

  • Top commodity trading and broking companies in India-20.29( -0.03%) 13-Mar-2025
top-arrow-market
Sensex 73999.38 -30.38  (-0.04) 13-Mar-2025
Previous Day Close
74029.76
Today's High/Low
High Low
  •  
  •  
74401.11 73898.1

Company News Details

ITC Ltd
Industry :  Cigarettes
BSE Code
ISIN Demat
Book Value()
500875
INE154A01025
58.2991836
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ITC
25.87
515679.51
EPS(TTM)
Face Value()
Div & Yield %
15.93
1
3.33
 

ITC Ltd
Stock Alert: ITC, Bharti Airtel, Britannia Industries, Hero Motocorp
Feb 07,2025
Earnings Today:

Mahindra & Mahindra, LIC, Mazagon Dock Shipbuilders, NHPC, Oil India, Wockhardt, 3M India, Archean Chemical Industries, AIA Engineering, Akzo Nobel India, Alembic, Alkem Laboratories, Astra Microwave Products, Balrampur Chini Mills, Balu Forge Industries, Borosil, Caplin Point Laboratories, Century Plyboards, Chemplast Sanmar, Cholamandalam Financial Holdings, Delhivery, Dreamfolks Services will declare their results later today.

Stocks to Watch:

ITC’s consolidated net profit fell 7.5% to Rs 4934.80 crore in Q3 FY25 as compared with Rs 5335.23 crore in Q3 FY24. Net sales increased 8.9% YoY to Rs 18,580.36 crore in Q3 FY25.

Bharti Airtel consolidated net profit soared 460.93% to Rs 16,134.6 crore in Q3 FY25 as against Rs 2,876.4 crore reported in Q3 FY24. Revenue from operations increased 19.07% YoY to Rs 45,129.3 crore in Q3 FY25,

Hero Motocorp reported 1.3% increase in consolidated net profit to Rs 1,107.55 crore in Q3 FY25 as compared with Rs 1093.41 crore in Q3 FY24. Net sales jumped 4.8% YoY to Rs 10,259.89 crore in Q3 FY25.

Britannia Industries’ consolidated net profit increased 4.6% to Rs 581.69 crore on 6.5% jump in net sales to Rs 4,463.30 crore in Q3 FY25 over Q3 FY24.

Zomato’s board approved the change in the name from ‘Zomato Limited’ to ‘Eternal Limited’. The company’s corporate website will transition from zomato.com to eternal.com. It will also change its stock ticker from ZOMATO to ETERNAL.

Dr Reddy’s Laboratories’ subsidiary, Dr. Reddy’s Swiss and Shanghai Henlius Biotech have entered into a license agreement for an in-licensing deal to register and commercialize the subcutaneous and intravenous formulations of the biosimilar product, ‘Daratumumab’ developed by Henlius.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.